Stock Earnings

Question 1

Quels sont les états financiers clés de Tango Therapeutics Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Tango Therapeutics Inc a un total d'actifs de $316, un bénéfice net loss de $-130

Question 2

Quels sont les ratios financiers clés pour TNGX ?

Accepted Answer

Le ratio de liquidité de Tango Therapeutics Inc est 2.7, la marge nette est -309.52, les ventes par action sont de $0.38.

Question 3

Comment les revenus de Tango Therapeutics Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Currently Tango Therapeutics Inc data is not available.

Question 4

Tango Therapeutics Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Tango Therapeutics Inc a un bénéfice net loss de $-130

Question 5

Tango Therapeutics Inc a-t-elle des passifs ?

Accepted Answer

yes, Tango Therapeutics Inc a un passif de 117

Question 6

Combien d'actions en circulation Tango Therapeutics Inc a-t-elle ?

Accepted Answer

Tango Therapeutics Inc a un total d'actions en circulation de 108

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	66	42	36	24	37	0
Revenue Growth (YoY)	53%	17%	50%	-35%	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	42	43	35	30	17	0
Research & Development	134	143	115	105	77	--
Operating Expenses	176	187	150	135	95	0
Other Non Operating Income (Expenses)	4	7	5	1	0	--
Pretax Income	-100	-130	-101	-108	-57	0
Income Tax Expense	0	0	0	0	0	0
Net Income	-100	-130	-101	-108	-58	0
Net Income Growth	-19%	28.99%	-6%	86%	--	--
Shares Outstanding (Diluted)	117.78	109.22	94.57	87.82	62.11	20.89
Shares Change (YoY)	9%	16%	8%	41%	197%	--
EPS (Diluted)	-0.85	-1.19	-1.07	-1.23	-0.94	-0.01
EPS Growth	-26%	11%	-13%	31%	9,300%	--
Free Cash Flow	-146	-132	-119	-116	-61	0
Free Cash Flow Per Share	-1.23	-1.2	-1.25	-1.32	-0.98	0
Gross Margin	--	--	--	--	--	--
Operating Margin	-166.66%	-345.23%	-316.66%	-462.5%	-156.75%	0%
Profit Margin	-151.51%	-309.52%	-280.55%	-450%	-156.75%	0%
Free Cash Flow Margin	-221.21%	-314.28%	-330.55%	-483.33%	-164.86%	0%
EBITDA	-108	-143	-112	-110	-58	--
EBITDA Margin	-163.63%	-340.47%	-311.11%	-458.33%	-156.75%	--
D&A For EBITDA	2	2	2	1	0	--
EBIT	-110	-145	-114	-111	-58	0
EBIT Margin	-166.66%	-345.23%	-316.66%	-462.5%	-156.75%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Tango Therapeutics Inc (TNGX) Price